Online Mindfulness Therapy Tested for Chronic Migraine and Childhood Stress
Tests online mindfulness therapy in adults with chronic migraine and difficult childhood experiences.
Plain-language title generated from the registry record
Registry title: Effects of Online Mindfulness Therapy on Pain and Stress in Adults With Chronic Migraine and Adverse Childhood Experiences
Key facts
- Where
- Bucaramanga, ColombiaSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with chronic migraine who also had difficult experiences in childhood. It tests an eight-week online mindfulness therapy program.
- Age
- 18 years or older
- Sex
- Men and women can join
- Disease stage
- Chronic migraine diagnosed by the ICHD-3 criteria
- Biomarker or test result
- A score of 4 or higher on the Adverse Childhood Experiences Questionnaire
Main reasons for not taking part
- Seeing, hearing, thinking or physical limits that prevent taking part in the therapy and home tasks
- Inflammatory, rheumatic or autoimmune disease
- Active cancer
- Pregnancy or breastfeeding
- Other nervous system conditions, central nervous system tumors, or a terminal illness that prevents follow-up
Read by machine on 12 November 2026.
Where in Colombia
- International Hospital of Colombia - Fundación Cardiovascular de ColombiaBucaramanga, ColombiaContact: Alexander Pabon Moreno, MD, NeurologistNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Fundación Cardiovascular de Colombia
- Trial code
- NCT07033520
- Record updated
- 26 June 2025
- Original description
This study aims to evaluate the effectiveness of an online Mindfulness-Based Cognitive Therapy (MBCT) program in reducing pain, stress-related symptoms, and improving functionality in adults with chronic migraine and a history of adverse childhood experiences (ACE). Participants will be randomly assigned to either the MBCT intervention group or a control group. The intervention is delivered entirely online over eight weeks. The study hypothesizes that MBCT will result in significant improvements in pain perception and stress-related symptoms compared to the control condition.Read full original descriptionShow less
Effects of Online Mindfulness-Based Cognitive Therapy on Pain, Stress-Related Symptoms, and Functionality in Adults With Chronic Migraine and Adverse Childhood Experiences at the International Hospital of Colombia
This study aims to evaluate the effectiveness of an online Mindfulness-Based Cognitive Therapy (MBCT) program in reducing pain, stress-related symptoms, and improving functionality in adults with chronic migraine and a history of adverse childhood experiences (ACE). Participants will be randomly assigned to either the MBCT intervention group or a control group. The intervention is delivered entirely online over eight weeks. The study hypothesizes that MBCT will result in significant improvements in pain perception and stress-related symptoms compared to the control condition.
Inclusion: Male and female patients aged 18 years or older with a diagnosis of chronic migraine according to the International Classification of Headache Disorders (ICHD-3), based on diagnostic criteria updated through 2018; Willingness to participate in online sessions from 6:00 PM to 8:00 PM on the scheduled day of the intervention; Male and female patients with a score of 4 or higher on the Adverse Childhood Experiences Questionnaire; Patients who provide informed consent.
Exclusion: Presence of systemic inflammatory disorders, including rheumatic and autoimmune diseases; Active malignancy; Pre-existing neurological conditions (e.g., epilepsy, neuromuscular disorders, metabolic diseases, among others); Diagnosis of terminal illnesses that prevent follow-up over time; Visual, auditory, cognitive, or functional limitations that prevent understanding of therapeutic activities or the ability to perform home tasks; Pregnancy or breastfeeding at the time of the study; Central nervous system tumors.